A 0 1 0 1 O
man 2 5 2 5 B-gender
who 6 9 6 9 O
is 10 12 10 12 O
sexually 13 21 13 21 O
active 22 28 22 28 O
with 29 33 29 33 O
a 34 35 34 35 O
woman 36 41 36 41 B-gender
of 42 44 42 44 O
childbearing 45 57 45 57 O
potential 58 67 58 67 O
and 68 71 68 71 O
has 72 75 72 75 O
not 76 79 76 79 O
had 80 83 80 83 O
a 84 85 84 85 O
vasectomy 86 95 86 95 B-treatment
must 96 100 96 100 O
agree 101 106 101 106 B-contraception_consent
to 107 109 107 109 I-contraception_consent
use 110 113 110 113 I-contraception_consent
a 114 115 114 115 I-contraception_consent
barrier 116 123 116 123 I-contraception_consent
method 124 130 124 130 I-contraception_consent
of 131 133 131 133 I-contraception_consent
birth 134 139 134 139 I-contraception_consent
control 140 147 140 147 I-contraception_consent
eg 148 150 148 150 O
, 150 151 150 151 O
either 152 158 152 158 O
condom 159 165 159 165 O
with 166 170 166 170 O
spermicidal 171 182 171 182 O
foam 183 187 183 187 O
/ 187 188 187 188 O
gel 188 191 188 191 O
/ 191 192 191 192 O
film 192 196 192 196 O
/ 196 197 196 197 O
cream 197 202 197 202 O
/ 202 203 202 203 O
suppository 203 214 203 214 O
or 215 217 215 217 O
partner 218 225 218 225 O
with 226 230 226 230 O
occlusive 231 240 231 240 O
cap 241 244 241 244 O
( 245 246 245 246 O
diaphragm 246 255 246 255 O
or 256 258 256 258 O
cervical 259 267 259 267 O
/ 267 268 267 268 O
vault 268 273 268 273 O
caps 274 278 274 278 O
) 278 279 278 279 O
with 280 284 280 284 O
spermicidal 285 296 285 296 O
foam 297 301 297 301 O
/ 301 302 301 302 O
gel 302 305 302 305 O
/ 305 306 305 306 O
film 306 310 306 310 O
/ 310 311 310 311 O
cream 311 316 311 316 O
/ 316 317 316 317 O
suppository 317 328 317 328 O
, 328 329 328 329 O
and 330 333 330 333 O
all 334 337 334 337 O
men 338 341 338 341 B-gender
must 342 346 342 346 O
also 347 351 347 351 O
not 352 355 352 355 O
donate 356 362 356 362 O
sperm 363 368 363 368 O
during 369 375 369 375 O
the 376 379 376 379 O
study 380 385 380 385 O
and 386 389 386 389 O
for 390 393 390 393 O
3 394 395 394 395 O
months 396 402 396 402 O
after 403 408 403 408 O
receiving 409 418 409 418 O
the 419 422 419 422 O
last 423 427 423 427 O
dose 428 432 428 432 O
of 433 435 433 435 O
study 436 441 436 441 O
drug 442 446 442 446 O

Aspartate 0 9 447 456 B-clinical_variable
aminotransferase 10 26 457 473 I-clinical_variable
( 27 28 474 475 I-clinical_variable
AST 28 31 475 478 I-clinical_variable
) 31 32 478 479 I-clinical_variable
and/or 33 39 480 486 O
alanine 40 47 487 494 B-clinical_variable
aminotransferase 48 64 495 511 I-clinical_variable
( 65 66 512 513 I-clinical_variable
ALT 66 69 513 516 I-clinical_variable
) 69 70 516 517 I-clinical_variable
= 71 72 518 519 O
< 72 73 519 520 O
3 74 75 521 522 B-upper_bound
x 76 77 523 524 I-upper_bound
upper 78 83 525 530 I-upper_bound
limit 84 89 531 536 I-upper_bound
of 90 92 537 539 I-upper_bound
normal 93 99 540 546 I-upper_bound
( 100 101 547 548 I-upper_bound
ULN 101 104 548 551 I-upper_bound
) 104 105 551 552 I-upper_bound

Diagnosis 0 9 553 562 O
of 10 12 563 565 O
acute 13 18 566 571 B-cancer
myeloid 19 26 572 579 I-cancer
leukemia 27 35 580 588 I-cancer
( 36 37 589 590 I-cancer
AML 37 40 590 593 I-cancer
) 40 41 593 594 I-cancer
( 42 43 595 596 O
other 43 48 596 601 O
than 49 53 602 606 O
acute 54 59 607 612 B-cancer
promyelocytic 60 73 613 626 I-cancer
leukemia 74 82 627 635 I-cancer
[ 83 84 636 637 I-cancer
APL 84 87 637 640 I-cancer
] 87 88 640 641 I-cancer
) 88 89 641 642 O
with 90 94 643 647 O
refractory 95 105 648 658 O
/ 105 106 658 659 O
relapsed 106 114 659 667 O
disease 115 122 668 675 O
; 122 123 675 676 O
patients 124 132 677 685 O
with 133 137 686 690 O
relapsed 138 146 691 699 O
/ 146 147 699 700 O
refractory 147 157 700 710 O
high 158 162 711 715 O
- 162 163 715 716 O
risk 163 167 716 720 O
( 168 169 721 722 O
[ 169 170 722 723 O
intermediate-2 170 184 723 737 B-lower_bound
or 185 187 738 740 O
higher 188 194 741 747 O
by 195 197 748 750 O
International 198 211 751 764 B-clinical_variable
Prognostic 212 222 765 775 I-clinical_variable
Scoring 223 230 776 783 I-clinical_variable
System 231 237 784 790 I-clinical_variable
[ 238 239 791 792 I-clinical_variable
IPSS 239 243 792 796 I-clinical_variable
] 243 244 796 797 I-clinical_variable
and/or 245 251 798 804 O
> 252 253 805 806 O
= 253 254 806 807 O
10 255 257 808 810 B-lower_bound
% 257 258 810 811 I-lower_bound
blasts 259 265 812 818 I-lower_bound
] 265 266 818 819 O
) 266 267 819 820 O

Eastern 0 7 821 828 B-clinical_variable
Cooperative 8 19 829 840 I-clinical_variable
Oncology 20 28 841 849 I-clinical_variable
Group 29 34 850 855 I-clinical_variable
( 35 36 856 857 I-clinical_variable
ECOG 36 40 857 861 I-clinical_variable
) 40 41 861 862 I-clinical_variable
performance 42 53 863 874 I-clinical_variable
status 54 60 875 881 I-clinical_variable
of 61 63 882 884 O
= 64 65 885 886 O
< 65 66 886 887 O
2 67 68 888 889 B-upper_bound
at 69 71 890 892 O
study 72 77 893 898 O
entry 78 83 899 904 O

FEV1 0 4 905 909 B-clinical_variable
testing 5 12 910 917 O
is 13 15 918 920 O
required 16 24 921 929 O
for 25 28 930 933 O
patients 29 37 934 942 O
suspected 38 47 943 952 O
of 48 50 953 955 O
having 51 57 956 962 O
COPD 58 62 963 967 B-chronic_disease
and 63 66 968 971 O
subjects 67 75 972 980 O
must 76 80 981 985 O
be 81 83 986 988 O
excluded 84 92 989 997 O
if 93 95 998 1000 O
FEV1 96 100 1001 1005 O
< 101 102 1006 1007 O
50 103 105 1008 1010 B-upper_bound
% 105 106 1010 1011 I-upper_bound
of 107 109 1012 1014 O
predicted 110 119 1015 1024 O
normal 120 126 1025 1031 O

Pregnant 0 8 1032 1040 B-pregnancy

Serum 0 5 1041 1046 B-clinical_variable
creatinine 6 16 1047 1057 I-clinical_variable
= 17 18 1058 1059 O
< 18 19 1059 1060 O
2 20 21 1061 1062 B-upper_bound
mg 22 24 1063 1065 I-upper_bound
/ 24 25 1065 1066 I-upper_bound
dL 25 27 1066 1068 I-upper_bound
and 28 31 1069 1072 O
estimated 32 41 1073 1082 B-clinical_variable
glomerular 42 52 1083 1093 I-clinical_variable
filtration 53 63 1094 1104 I-clinical_variable
rate 64 68 1105 1109 I-clinical_variable
or 69 71 1110 1112 O
creatinine 72 82 1113 1123 B-clinical_variable
clearance 83 92 1124 1133 I-clinical_variable
> 93 94 1134 1135 O
= 94 95 1135 1136 O
20 96 98 1137 1139 B-lower_bound
ml 99 101 1140 1142 I-lower_bound
/ 101 102 1142 1143 I-lower_bound
min 102 105 1143 1146 I-lower_bound

Total 0 5 1147 1152 O
bilirubin 6 15 1153 1162 B-clinical_variable
= 16 17 1163 1164 O
< 17 18 1164 1165 O
2 19 20 1166 1167 B-upper_bound
mg 21 23 1168 1170 I-upper_bound
/ 23 24 1170 1171 I-upper_bound
dL 24 26 1171 1173 I-upper_bound

Use 0 3 1174 1177 O
of 4 6 1178 1180 O
hydroxyurea 7 18 1181 1192 B-treatment
to 19 21 1193 1195 O
control 22 29 1196 1203 O
proliferative 30 43 1204 1217 B-chronic_disease
disease 44 51 1218 1225 I-chronic_disease

Women 0 5 1226 1231 B-gender
of 6 8 1232 1234 O
childbearing 9 21 1235 1247 O
potential 22 31 1248 1257 O
must 32 36 1258 1262 O
be 37 39 1263 1265 O
practicing 40 50 1266 1276 B-contraception_consent
a 51 52 1277 1278 I-contraception_consent
highly 53 59 1279 1285 I-contraception_consent
effective 60 69 1286 1295 I-contraception_consent
method 70 76 1296 1302 I-contraception_consent
of 77 79 1303 1305 I-contraception_consent
birth 80 85 1306 1311 I-contraception_consent
control 86 93 1312 1319 I-contraception_consent
consistent 94 104 1320 1330 I-contraception_consent
with 105 109 1331 1335 I-contraception_consent
local 110 115 1336 1341 I-contraception_consent
regulations 116 127 1342 1353 I-contraception_consent
regarding 128 137 1354 1363 I-contraception_consent
the 138 141 1364 1367 I-contraception_consent
use 142 145 1368 1371 I-contraception_consent
of 146 148 1372 1374 I-contraception_consent
birth 149 154 1375 1380 I-contraception_consent
control 155 162 1381 1388 I-contraception_consent
methods 163 170 1389 1396 I-contraception_consent
for 171 174 1397 1400 I-contraception_consent
subjects 175 183 1401 1409 I-contraception_consent
participating 184 197 1410 1423 I-contraception_consent
in 198 200 1424 1426 I-contraception_consent
clinical 201 209 1427 1435 I-contraception_consent
studies 210 217 1436 1443 I-contraception_consent
: 217 218 1443 1444 O
eg 219 221 1445 1447 O
, 221 222 1447 1448 O
established 223 234 1449 1460 B-contraception_consent
use 235 238 1461 1464 I-contraception_consent
of 239 241 1465 1467 I-contraception_consent
oral 242 246 1468 1472 I-contraception_consent
, 246 247 1472 1473 O
injected 248 256 1474 1482 B-contraception_consent
or 257 259 1483 1485 I-contraception_consent
implanted 260 269 1486 1495 I-contraception_consent
hormonal 270 278 1496 1504 I-contraception_consent
methods 279 286 1505 1512 I-contraception_consent
of 287 289 1513 1515 I-contraception_consent
contraception 290 303 1516 1529 I-contraception_consent

breast 0 6 1530 1536 O
feeding 7 14 1537 1544 O
females 15 22 1545 1552 B-gender

has 0 3 1553 1556 O
a 4 5 1557 1558 O
history 6 13 1559 1566 O
of 14 16 1567 1569 O
another 17 24 1570 1577 O
malignancy 25 35 1578 1588 B-cancer
within 36 42 1589 1595 O
5 43 44 1596 1597 B-upper_bound
years 45 50 1598 1603 I-upper_bound
before 51 57 1604 1610 O
cycle 58 63 1611 1616 O
1 64 65 1617 1618 O
, 65 66 1618 1619 O
day 67 70 1620 1623 O
1 71 72 1624 1625 O
( 73 74 1626 1627 O
exceptions 74 84 1627 1637 O
are 85 88 1638 1641 O
squamous 89 97 1642 1650 B-cancer
and 98 101 1651 1654 I-cancer
basal 102 107 1655 1660 I-cancer
cell 108 112 1661 1665 I-cancer
carcinomas 113 123 1666 1676 I-cancer
of 124 126 1677 1679 I-cancer
the 127 130 1680 1683 I-cancer
skin 131 135 1684 1688 I-cancer
and 136 139 1689 1692 O
carcinoma 140 149 1693 1702 B-cancer
in 150 152 1703 1705 I-cancer
situ 153 157 1706 1710 I-cancer
of 158 160 1711 1713 I-cancer
the 161 164 1714 1717 I-cancer
cervix 165 171 1718 1724 I-cancer
, 171 172 1724 1725 O
or 173 175 1726 1728 O
malignancy 176 186 1729 1739 O
that 187 191 1740 1744 O
in 192 194 1745 1747 O
the 195 198 1748 1751 O
opinion 199 206 1752 1759 O
of 207 209 1760 1762 O
the 210 213 1763 1766 O
investigator 214 226 1767 1779 O
, 226 227 1779 1780 O
with 228 232 1781 1785 O
concurrence 233 244 1786 1797 O
with 245 249 1798 1802 O
the 250 253 1803 1806 O
IND 254 257 1807 1810 O
office 258 264 1811 1817 O
and 265 268 1818 1821 O
supporter 269 278 1822 1831 O
's 278 280 1831 1833 O
medical 281 288 1834 1841 O
monitor 289 296 1842 1849 O
, 296 297 1849 1850 O
is 298 300 1851 1853 O
considered 301 311 1854 1864 O
cured 312 317 1865 1870 O
with 318 322 1871 1875 O
minimal 323 330 1876 1883 O
risk 331 335 1884 1888 O
of 336 338 1889 1891 O
recurrence 339 349 1892 1902 O
) 349 350 1902 1903 O

has 0 3 1904 1907 O
any 4 7 1908 1911 O
concurrent 8 18 1912 1922 O
medical 19 26 1923 1930 O
condition 27 36 1931 1940 O
or 37 39 1941 1943 O
disease 40 47 1944 1951 O
( 48 49 1952 1953 O
eg 49 51 1953 1955 O
, 51 52 1955 1956 O
active 53 59 1957 1963 O
systemic 60 68 1964 1972 B-chronic_disease
infection 69 78 1973 1982 I-chronic_disease
, 78 79 1982 1983 O
laboratory 80 90 1984 1994 O
abnormalities 91 104 1995 2008 O
) 104 105 2008 2009 O
that 106 110 2010 2014 O
is 111 113 2015 2017 O
likely 114 120 2018 2024 O
to 121 123 2025 2027 O
interfere 124 133 2028 2037 O
with 134 138 2038 2042 O
study 139 144 2043 2048 O
procedures 145 155 2049 2059 O
or 156 158 2060 2062 O
results 159 166 2063 2070 O
, 166 167 2070 2071 O
or 168 170 2072 2074 O
that 171 175 2075 2079 O
in 176 178 2080 2082 O
the 179 182 2083 2086 O
opinion 183 190 2087 2094 O
of 191 193 2095 2097 O
the 194 197 2098 2101 O
investigator 198 210 2102 2114 O
would 211 216 2115 2120 O
constitute 217 227 2121 2131 O
a 228 229 2132 2133 O
hazard 230 236 2134 2140 O
for 237 240 2141 2144 O
participating 241 254 2145 2158 O
in 255 257 2159 2161 O
this 258 262 2162 2166 O
study 263 268 2167 2172 O

has 0 3 2173 2176 O
clinically 4 14 2177 2187 O
significant 15 26 2188 2199 O
cardiac 27 34 2200 2207 B-chronic_disease
disease 35 42 2208 2215 I-chronic_disease
, 42 43 2215 2216 O
including 44 53 2217 2226 O
: 53 54 2226 2227 O
myocardial 55 65 2228 2238 B-chronic_disease
infarction 66 76 2239 2249 I-chronic_disease
within 77 83 2250 2256 O
1 84 85 2257 2258 B-upper_bound
year 86 90 2259 2263 I-upper_bound
before 91 97 2264 2270 O
cycle 98 103 2271 2276 O
1 104 105 2277 2278 O
, 105 106 2278 2279 O
day 107 110 2280 2283 O
1 111 112 2284 2285 O
, 112 113 2285 2286 O
or 114 116 2287 2289 O
unstable 117 125 2290 2298 O
or 126 128 2299 2301 O
uncontrolled 129 141 2302 2314 B-chronic_disease
disease 142 149 2315 2322 I-chronic_disease
/ 149 150 2322 2323 I-chronic_disease
condition 150 159 2323 2332 I-chronic_disease
related 160 167 2333 2340 O
to 168 170 2341 2343 O
or 171 173 2344 2346 O
affecting 174 183 2347 2356 O
cardiac 184 191 2357 2364 O
function 192 200 2365 2373 O
( 201 202 2374 2375 O
eg 202 204 2375 2377 O
, 204 205 2377 2378 O
unstable 206 214 2379 2387 B-chronic_disease
angina 215 221 2388 2394 I-chronic_disease
, 221 222 2394 2395 O
congestive 223 233 2396 2406 B-chronic_disease
heart 234 239 2407 2412 I-chronic_disease
failure 240 247 2413 2420 I-chronic_disease
, 247 248 2420 2421 O
New 249 252 2422 2425 B-chronic_disease
York 253 257 2426 2430 I-chronic_disease
Heart 258 263 2431 2436 I-chronic_disease
Association 264 275 2437 2448 I-chronic_disease
class 276 281 2449 2454 I-chronic_disease
III 282 285 2455 2458 I-chronic_disease
- 285 286 2458 2459 I-chronic_disease
IV 286 288 2459 2461 I-chronic_disease
) 288 289 2461 2462 O

has 0 3 2463 2466 O
known 4 9 2467 2472 O
chronic 10 17 2473 2480 B-chronic_disease
obstructive 18 29 2481 2492 I-chronic_disease
pulmonary 30 39 2493 2502 I-chronic_disease
disease 40 47 2503 2510 I-chronic_disease
( 48 49 2511 2512 I-chronic_disease
COPD 49 53 2512 2516 I-chronic_disease
) 53 54 2516 2517 I-chronic_disease
with 55 59 2518 2522 O
a 60 61 2523 2524 O
forced 62 68 2525 2531 B-clinical_variable
expiratory 69 79 2532 2542 I-clinical_variable
volume 80 86 2543 2549 I-clinical_variable
in 87 89 2550 2552 I-clinical_variable
1 90 91 2553 2554 I-clinical_variable
second 92 98 2555 2561 I-clinical_variable
( 99 100 2562 2563 I-clinical_variable
FEV1 100 104 2563 2567 I-clinical_variable
) 104 105 2567 2568 I-clinical_variable
< 106 107 2569 2570 O
50 108 110 2571 2573 B-upper_bound
% 110 111 2573 2574 I-upper_bound
of 112 114 2575 2577 O
predicted 115 124 2578 2587 O
normal 125 131 2588 2594 O

has 0 3 2595 2598 O
received 4 12 2599 2607 O
a 13 14 2608 2609 O
cumulative 15 25 2610 2620 O
dose 26 30 2621 2625 O
of 31 33 2626 2628 O
corticosteroids 34 49 2629 2644 B-treatment
more 50 54 2645 2649 O
than 55 59 2650 2654 O
the 60 63 2655 2658 O
equivalent 64 74 2659 2669 O
of 75 77 2670 2672 O
> 78 79 2673 2674 O
= 79 80 2674 2675 O
140 81 84 2676 2679 B-lower_bound
mg 85 87 2680 2682 I-lower_bound
of 88 90 2683 2685 O
prednisone 91 101 2686 2696 O
within 102 108 2697 2703 O
the 109 112 2704 2707 O
2 113 114 2708 2709 B-upper_bound
week 115 119 2710 2714 I-upper_bound
period 120 126 2715 2721 O
before 127 133 2722 2728 O
cycle 134 139 2729 2734 O
1 140 141 2735 2736 O
, 141 142 2736 2737 O
day 143 146 2738 2741 O
1 147 148 2742 2743 O

has 0 3 2744 2747 O
received 4 12 2748 2756 O
daratumumab 13 24 2757 2768 B-treatment
or 25 27 2769 2771 O
other 28 33 2772 2777 O
anti 34 38 2778 2782 B-treatment
- 38 39 2782 2783 I-treatment
CD38 39 43 2783 2787 I-treatment
therapies 44 53 2788 2797 I-treatment
previously 54 64 2798 2808 O

known 0 5 2809 2814 O
to 6 8 2815 2817 O
be 9 11 2818 2820 O
seropositive 12 24 2821 2833 O
for 25 28 2834 2837 O
human 29 34 2838 2843 B-chronic_disease
immunodeficiency 35 51 2844 2860 I-chronic_disease
virus 52 57 2861 2866 I-chronic_disease
( 58 59 2867 2868 I-chronic_disease
HIV 59 62 2868 2871 I-chronic_disease
) 62 63 2871 2872 I-chronic_disease
or 64 66 2873 2875 O
hepatitis 67 76 2876 2885 B-chronic_disease
B 77 78 2886 2887 I-chronic_disease
( 79 80 2888 2889 O
defined 80 87 2889 2896 O
by 88 90 2897 2899 O
a 91 92 2900 2901 O
positive 93 101 2902 2910 O
test 102 106 2911 2915 O
for 107 110 2916 2919 O
hepatitis 111 120 2920 2929 B-clinical_variable
B 121 122 2930 2931 I-clinical_variable
surface 123 130 2932 2939 I-clinical_variable
antigen 131 138 2940 2947 I-clinical_variable
[ 139 140 2948 2949 I-clinical_variable
HBsAg 140 145 2949 2954 I-clinical_variable
] 145 146 2954 2955 I-clinical_variable
or 147 149 2956 2958 O
antibodies 150 160 2959 2969 O
to 161 163 2970 2972 O
hepatitis 164 173 2973 2982 B-clinical_variable
B 174 175 2983 2984 I-clinical_variable
surface 176 183 2985 2992 I-clinical_variable
and 184 187 2993 2996 I-clinical_variable
core 188 192 2997 3001 I-clinical_variable
antigens 193 201 3002 3010 I-clinical_variable
[ 202 203 3011 3012 O
anti 203 207 3012 3016 B-clinical_variable
- 207 208 3016 3017 I-clinical_variable
HBs 208 211 3017 3020 I-clinical_variable
and 212 215 3021 3024 O
anti 216 220 3025 3029 B-clinical_variable
- 220 221 3029 3030 I-clinical_variable
HBc 221 224 3030 3033 I-clinical_variable
, 224 225 3033 3034 O
respectively 226 238 3035 3047 O
] 238 239 3047 3048 O
) 239 240 3048 3049 O
or 241 243 3050 3052 O
hepatitis 244 253 3053 3062 B-chronic_disease
C 254 255 3063 3064 I-chronic_disease
( 256 257 3065 3066 O
anti 257 261 3066 3070 B-clinical_variable
- 261 262 3070 3071 I-clinical_variable
hepatitis 262 271 3071 3080 I-clinical_variable
C 272 273 3081 3082 I-clinical_variable
virus 274 279 3083 3088 I-clinical_variable
[ 280 281 3089 3090 I-clinical_variable
HCV 281 284 3090 3093 I-clinical_variable
] 284 285 3093 3094 I-clinical_variable
antibody 286 294 3095 3103 I-clinical_variable
positive 295 303 3104 3112 O
or 304 306 3113 3115 O
HCV 307 310 3116 3119 B-clinical_variable
- 310 311 3119 3120 I-clinical_variable
ribonucleic 311 322 3120 3131 I-clinical_variable
acid 323 327 3132 3136 I-clinical_variable
[ 328 329 3137 3138 I-clinical_variable
RNA 329 332 3138 3141 I-clinical_variable
] 332 333 3141 3142 I-clinical_variable
quantitation 334 346 3143 3155 I-clinical_variable
positive 347 355 3156 3164 O
) 355 356 3164 3165 O

male 0 4 3166 3170 B-gender
partner 5 12 3171 3178 O
sterilization 13 26 3179 3192 O
( 27 28 3193 3194 O
the 28 31 3194 3197 O
vasectomized 32 44 3198 3210 O
partner 45 52 3211 3218 O
should 53 59 3219 3225 O
be 60 62 3226 3228 O
the 63 66 3229 3232 O
sole 67 71 3233 3237 O
partner 72 79 3238 3245 O
for 80 83 3246 3249 O
that 84 88 3250 3254 O
subject 89 96 3255 3262 O
) 96 97 3262 3263 O

provided 0 8 3264 3272 O
there 9 14 3273 3278 O
is 15 17 3279 3281 O
no 18 20 3282 3284 O
active 21 27 3285 3291 O
graft 28 33 3292 3297 B-clinical_variable
- 33 34 3297 3298 I-clinical_variable
versus 34 40 3298 3304 I-clinical_variable
- 40 41 3304 3305 I-clinical_variable
host 41 45 3305 3309 I-clinical_variable
disease 46 53 3310 3317 I-clinical_variable
( 54 55 3318 3319 I-clinical_variable
GVHD 55 59 3319 3323 I-clinical_variable
) 59 60 3323 3324 I-clinical_variable
> 61 62 3325 3326 O
grade 63 68 3327 3332 B-lower_bound
1 69 70 3333 3334 I-lower_bound

